(Q78311651)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

title

Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

author name string

Michael Hedenus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Sören Hansen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Kerry Taylor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Chris Arthur

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Bertold Emmerich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Claire Dewey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

David Watson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Gregory Rossi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Anders Osterborg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Darbepoetin alfa 990114 Study Group

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

language of work or name

English

0 references

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

13 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

page(s)

79-86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

Recombinant human erythropoietin and the anemia of multiple myeloma

13 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Development and characterization of novel erythropoiesis stimulating protein (NESP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Chemotherapy-induced anemia in adults: incidence and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Erythropoietin treatment of anemia associated with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03774.X

10.1046/J.1365-2141.2002.03774.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358906%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1 reference